Pharmaceutical Inspection: Compliance by Design

End-to-end machine vision and serialization solutions engineered for pharmaceutical manufacturing—ensuring DSCSA, EU FMD, and global regulatory compliance while achieving zero-defect production.

DSCSA Compliant EU FMD Ready FDA 21 CFR Part 11 GS1 Standards Annex 11 Validated
Request Compliance Assessment View Pharma Solutions
💊🔍✅

Complete track & trace from packaging to patient

Serialization Aggregation Label Verify Audit Trail

Meeting Global Pharmaceutical Regulations

Our systems are purpose-built to address the complex compliance landscape of modern pharma manufacturing

🇺 DSCSA (USA)

Drug Supply Chain Security Act requirements for product identification, verification, and transaction history.

  • Unique serial number on each saleable unit
  • 2D DataMatrix with GTIN, serial, lot, expiry
  • Verification at package level (VRS)
  • Electronic interoperability (EPCIS)

🇪 EU FMD (Europe)

EU Falsified Medicines Directive mandates for safety features and repository connectivity.

  • Unique identifier (UI) on packaging
  • Anti-tampering device verification
  • EMVS/NMVS repository integration
  • Decommissioning at point of dispensing

🌍 Global Standards

Harmonized approaches for emerging markets and export compliance.

  • GS1 standards for data structure
  • WHO GDP guidelines adherence
  • Local regulatory adaptations (Brazil, China, India)
  • Multi-language label verification

Achieving 100% DSCSA Compliance on High-Speed Blister Lines

🏭 Top 10 Pharma Company 🌍 3 Countries, 8 Lines 📅 Deployed Q3 2024

Challenge: The manufacturer needed to serialize and verify millions of blister packs monthly across multiple sites while meeting DSCSA deadlines, maintaining line speeds of 400 packs/minute, and keeping false reject rates below 0.5%.

  • Deployed Unicus Vision Label Inspection + Serialization systems on 8 high-speed lines
  • Integrated with existing SAP ME and repository systems via EPCIS 2.0
  • Implemented AI-powered defect classification to reduce false rejects
  • Established centralized monitoring dashboard for all sites
100%DSCSA Compliance Achieved
0.18%False Reject Rate
22%OEE Improvement
$3.2MAnnual Savings

Ensure Compliance. Protect Patients. Prevent Recalls.

Our pharma specialists will conduct a free gap analysis of your current serialization and inspection processes against DSCSA/EU FMD requirements.